The Mount Sinai IBD Biobank and Data Repository
Age: 0 - 100 years
Gender: All
Healthy Subjects: No
Recruitment Status: Recruiting
Start Date: April 14, 2025
End Date: February 17, 2026
Approximately 1.4 million people in the United States have been affected by inflammatory bowel disease (IBD), and the number is growing. The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is conducting research to understand the causes of IBD and advance treatment approaches. Through this initiative, we intend to collect and store data from a variety of patients to improve our understanding of the underlying causes and mechanisms of IBD, which includes Crohn’s disease and ulcerative colitis. Our results will help doctors create more personalized treatments and improve diagnosis and care for people living with IBD.
Who can participate in the study?
All adult and pediatric patients of any age who are receiving care at the IBD Center.
What does participation involve?
Once the IBD Center receives consent from you, the patient, the research team can use the stored data regarding your IBD treatment to help answer questions related to the disease. Researchers will have access to any of your tissue that may have been already collected and stored with the Mount Sinai Biorepository and Pathology facility. In the future, researchers may ask you to provide samples such as blood, biopsies, or stool; however, that would be completely voluntary.
If you are interested in participating, please call or email us, or ask your provider at your next visit to the IBD Center.